HER2 POSITIVE

Clinical trials for HER2 POSITIVE explained in plain language.

Never miss a new study

Get alerted when new HER2 POSITIVE trials appear

Sign up with your email to follow new studies for HER2 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New drug BL-M17D1 targets Hard-to-Treat HER2 cancers in early trial

Disease control Ongoing

This early-stage study tests a new drug called BL-M17D1 in 120 adults with advanced solid tumors that have HER2 protein or gene changes. The main goals are to check safety, find the right dose, and see if the drug shrinks tumors. Participants must have tried at least one standard…

Matched conditions: HER2 POSITIVE

Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control

Last updated Jun 27, 2026 07:56 UTC

HER2 POSITIVE

Get alerted when new HER2 POSITIVE trials appear

New drug BL-M17D1 targets Hard-to-Treat HER2 cancers in early trial